摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1H-Benzimidazole-6-carboximidamide, 2-(2-(5-(aminoiminomethyl)-2-benzofuranyl)ethenyl)- | 907169-69-1

中文名称
——
中文别名
——
英文名称
1H-Benzimidazole-6-carboximidamide, 2-(2-(5-(aminoiminomethyl)-2-benzofuranyl)ethenyl)-
英文别名
2-[(E)-2-(5-carbamimidoyl-1-benzofuran-2-yl)ethenyl]-3H-benzimidazole-5-carboximidamide
1H-Benzimidazole-6-carboximidamide, 2-(2-(5-(aminoiminomethyl)-2-benzofuranyl)ethenyl)-化学式
CAS
907169-69-1
化学式
C19H16N6O
mdl
——
分子量
344.4
InChiKey
OOKWWPFCCCMWIS-ZZXKWVIFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    142
  • 氢给体数:
    5
  • 氢受体数:
    4

文献信息

  • METHODS OF INHIBITING VIRAL INFECTION
    申请人:Functional Genetics, Inc.
    公开号:EP2207801A1
    公开(公告)日:2010-07-21
  • Antiviral Compounds and Methods of Using Thereof
    申请人:Aman Mohammad Javad
    公开号:US20090012107A1
    公开(公告)日:2009-01-08
    Disclosed herein are compounds which exhibit antiviral activity against a plurality of viruses belonging to different families such as Bornaviridae, Filoviridae, Paramyxoviridae, Rhabdoviridae, Arenaviridae, Bunyaviridae, Orthomyxoviridae, and Poxviridae. Thus, methods of preventing, inhibiting, or reducing the viral activity of various viruses are provided as well as methods of treating viral infections.
  • METHOHDS OF INHIBITING VIRAL INFECTION
    申请人:Kinch Michael
    公开号:US20090170890A1
    公开(公告)日:2009-07-02
    A method of inhibiting viral infection in a mammal in need of same, includes administering an effective amount of at least one of the compounds of FGI-103 which are represented by 273, 365 and 510 either prophylactically to prevent viral infection, or therapeutically following viral infection. These compounds appear to selectively inhibit Caspase 8 as a method of preventing infective viral particle release. They can be administered IV, IP, orally or via other conventional administration routes. The compounds are highly effective, requiring relatively low dosages on the order of 1 ng/kg-200 mg/kg of body weight.
  • NOVEL THERAPEUTICS FOR BRAIN CANCER
    申请人:The Regents of the University of California
    公开号:US20170182049A1
    公开(公告)日:2017-06-29
    Provided herein are novel compositions and methods to inhibit Olig2 activity. The Olig2 inhibitors and methods of using the same are useful, inter alia, for treating cancer. In particular the Olig2 inhibitors may be used to treat glioblastoma. Further, provided are peptide compositions capable of inhibiting Olig 2.
  • US7999001B2
    申请人:——
    公开号:US7999001B2
    公开(公告)日:2011-08-16
查看更多